glutathione and diabetes type 1 Overview of diabetes: etiologies, immune mechanisms & related genes, genetic & metabolic therapies The mechanism of hyperglycemic conditions

Bottom line: If you want powerful monotherapy, GLP-1/GIP agents lead today

GHK-CU Strengths and Limitations For detailed GHK-CU dosing information , the standard approach involves 1-2mg daily for injectable protocols or 2-4% concentration for topical applications

It was developed as a structurally defined research tool to investigate cytoprotective and anti-inflammatory signalling mechanisms independent of red blood cell production

2 Pregabalin should be initiated at a dosage of 75 mg twice daily and titrated up to a target of 225 mg twice daily, depending on the patients creatinine clearance

Designed for daily use

So, we decided the study design be based on the pre-post intervention model